Supernus Pharmaceuticals
SUPN
#4236
Rank
$1.86 B
Marketcap
$34.11
Share price
1.10%
Change (1 day)
-6.27%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2023 (TTM): $5.18 M

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are $5.18 M. a decrease over its 2022 earnings that were of $67.81 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023$5.18 M-92.36%
2022$67.81 M-29.8%
2021$96.59 M-49.79%
2020$0.19 B12.99%
2019$0.17 B7.58%
2018$0.15 B54.9%
2017$0.10 B84.25%
2016$55.46 M202.27%
2015$18.34 M-462.04%
2014-$5.07 M-94%
2013-$84.43 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$16.97 B 327,291.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.66 B 128,449.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.55 B 126,339.04%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.44 B 162,708.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.22 B-4,190.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.33 B 25,625.31%๐Ÿ‡บ๐Ÿ‡ธ USA